Free Trial

Bristol-Myers Squibb (BMY) News Today

→ DON’T buy gold until you read this (From Sasco Gold LLC) (Ad)
Free BMY Stock Alerts
$42.58
+1.10 (+2.65%)
(As of 06/10/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 10 at 2:53 PM | marketbeat.com
Strategic Global Advisors LLC Sells 70,391 Shares of Bristol-Myers Squibb (NYSE:BMY)
Strategic Global Advisors LLC decreased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 40.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 102,075 shares of the biopharmaceutical company's stock after selling 70,391 shares
June 10 at 1:46 PM | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Shares Up 0.9%
Bristol-Myers Squibb (NYSE:BMY) Trading Up 0.9%
June 10 at 12:00 PM | investorplace.com
7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
June 9 at 2:54 PM | marketbeat.com
Shell Asset Management Co. Sells 22,630 Shares of Bristol-Myers Squibb (NYSE:BMY)
Shell Asset Management Co. lowered its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 23.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,926 shares of the biopharmaceutical compa
June 9 at 3:34 AM | seekingalpha.com
Bristol Myers: Quality Fundamentals Suppressed By Interest Rates
June 8 at 5:18 PM | marketbeat.com
Westwood Holdings Group Inc. Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)
Westwood Holdings Group Inc. lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 366,246 shares of the biopharmaceutical company's stock
June 8 at 9:00 AM | investorplace.com
The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024
June 8 at 8:38 AM | americanbankingnews.com
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
June 7 at 9:46 PM | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Schroder Investment Management Group
Schroder Investment Management Group lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,465,916 shares of
June 7 at 1:40 PM | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Trading 1.6% Higher
Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 1.6%
June 7 at 12:09 AM | marketbeat.com
Pinebridge Investments L.P. Buys 772,635 Shares of Bristol-Myers Squibb (NYSE:BMY)
Pinebridge Investments L.P. lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 71.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,847,929 shares of the biopharmaceutical company's stock afte
June 6, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 1.1%
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 1.1%
June 6, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by American International Group Inc.
American International Group Inc. lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 516,832 shar
June 5, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Trading Down 1.5%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 1.5%
June 5, 2024 | prnewswire.com
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
June 4, 2024 | marketbeat.com
Peapack Gladstone Financial Corp Sells 32,032 Shares of Bristol-Myers Squibb (NYSE:BMY)
Peapack Gladstone Financial Corp decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 5.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 602,095 shares of the biopharmaceutical company's
June 4, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 0.1%
Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 0.1%
June 4, 2024 | seekingalpha.com
Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84%
June 4, 2024 | businesswire.com
Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 4, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Holderness Investments Co.
Holderness Investments Co. raised its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 70.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,232 shares of the biopharmaceutical company's stock after purchas
June 3, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 2.4%
Bristol-Myers Squibb (NYSE:BMY) Trading Up 2.4%
June 3, 2024 | businesswire.com
Bristol Myers Squibb's Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
June 3, 2024 | businesswire.com
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
June 3, 2024 | fool.com
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
June 3, 2024 | seekingalpha.com
Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss
June 2, 2024 | marketbeat.com
Alberta Investment Management Corp Purchases 18,902 Shares of Bristol-Myers Squibb (NYSE:BMY)
Alberta Investment Management Corp lifted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 39.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 66,802 shares of the biopharmaceutical company's stock
June 2, 2024 | reuters.com
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
June 1, 2024 | marketbeat.com
Chiron Capital Management LLC Sells 25,095 Shares of Bristol-Myers Squibb (NYSE:BMY)
Chiron Capital Management LLC lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 5.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 444,615 shares of the biopharmaceutical company's stock after selling 25,095 shares during the qua
June 1, 2024 | businesswire.com
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
May 31, 2024 | marketbeat.com
Pingora Partners LLC Makes New $1.06 Million Investment in Bristol-Myers Squibb (NYSE:BMY)
Pingora Partners LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,684 shares of the biopharmaceutical comp
May 31, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Trading Up 1.1%
Bristol-Myers Squibb (NYSE:BMY) Shares Up 1.1%
May 31, 2024 | americanbankingnews.com
Bristol-Myers Squibb (NYSE:BMY) Receives $60.00 Consensus PT from Brokerages
May 30, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Position Increased by Fiduciary Trust Co
Fiduciary Trust Co lifted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 222,208 shares of the biopharmaceutical company's stock after buying an additional 30,257 share
May 30, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Trading Up 0.4%
Bristol-Myers Squibb (NYSE:BMY) Shares Up 0.4%
May 30, 2024 | reuters.com
US FDA allows use of Bristol's cell therapy for rare blood cancer
May 30, 2024 | businesswire.com
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma
May 29, 2024 | marketbeat.com
TFO Wealth Partners LLC Has $1.05 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)
TFO Wealth Partners LLC grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 48,673.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,485 shares of the biopharmaceutical company's
May 29, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.9%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.9%
May 29, 2024 | msn.com
Bristol-Myers gets EU approval for Opdivo for bladder cancer
May 29, 2024 | businesswire.com
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
May 28, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Journey Advisory Group LLC
Journey Advisory Group LLC decreased its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 50.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,040 shares of the biopharmaceutical comp
May 28, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.8%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.8%
May 28, 2024 | finance.yahoo.com
ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries
May 28, 2024 | stocknews.com
Dividend Stability and Growth in Pharma: Pfizer (PFE) vs. Bristol-Myers Squibb (BMY)
May 28, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Hits New 1-Year Low at $41.04
Bristol-Myers Squibb (NYSE:BMY) Sets New 1-Year Low at $41.04
May 28, 2024 | businesswire.com
Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb
May 28, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Receives Average Recommendation of "Hold" from Brokerages
Bristol-Myers Squibb (NYSE:BMY - Get Free Report) has been assigned an average rating of "Hold" from the nineteen ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation a
May 27, 2024 | marketbeat.com
United Services Automobile Association Acquires 542,253 Shares of Bristol-Myers Squibb (NYSE:BMY)
United Services Automobile Association increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 965.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 598,432 shares of the
May 27, 2024 | marketbeat.com
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.7%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.7%
May 27, 2024 | investorplace.com
3 Blue-Chip Stocks to Buy at 52-Week Lows in May
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

Don’t make this retirement mistake (Ad)

If you have over $100,000 in your 401K or IRA… Then listen closely… Your money is rotting away, and you might not even realize it.

Reserve your seat here.

BMY Media Mentions By Week

BMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMY
News Sentiment
▼
0.74

0.76
▲
Average
Medical
News Sentiment

BMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMY Articles
This Week
▼
20

23
▲
BMY Articles
Average Week

Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:BMY) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
Bill Clinton Backing Biden Replacement???
Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...
The Freeport Society | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Missed NVDA? Buy this AI stock NOW
After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...
Chaikin Analytics | Sponsored